688185 Stock | | | 61.23 0.13 0.21% |
Cansino Biologics financial indicator trend analysis is way more than just evaluating Cansino Biologics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cansino Biologics is a good investment. Please check the relationship between Cansino Biologics Net Income From Continuing Ops and its Selling General Administrative accounts. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Cansino Biologics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in nation.
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Cansino Biologics Net Income From Continuing Ops account and
Selling General Administrative. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between Cansino Biologics' Net Income From Continuing Ops and Selling General Administrative is -0.57. Overlapping area represents the amount of variation of Net Income From Continuing Ops that can explain the historical movement of Selling General Administrative in the same time period over historical financial statements of Cansino Biologics, assuming nothing else is changed. The correlation between historical values of Cansino Biologics' Net Income From Continuing Ops and Selling General Administrative is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Income From Continuing Ops of Cansino Biologics are associated (or correlated) with its Selling General Administrative. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Selling General Administrative has no effect on the direction of Net Income From Continuing Ops i.e., Cansino Biologics' Net Income From Continuing Ops and Selling General Administrative go up and down completely randomly.
Correlation Coefficient | -0.57 |
Relationship Direction | Negative |
Relationship Strength | Very Weak |
Most indicators from Cansino Biologics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cansino Biologics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Cansino Biologics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in nation.
The current year's Selling General Administrative is expected to grow to about 680.2
M, whereas
Tax Provision is forecasted to decline to (12
M).
Balance Sheet is a snapshot of the
financial position of Cansino Biologics at a specified time, usually calculated after every quarter, six months, or one year. Cansino Biologics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Cansino Biologics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Cansino currently owns. An asset can also be divided into two categories, current and non-current.